Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, ...

Regeneron and Sanofi announced positive data from ODYSSEY ESCAPE, a Phase 3 study which evaluated Praluent (alirocumab) in patients with heterozygous familial hypercholesterolemia (HeFH) requiring ...

It has previously been shown that a single LDL apheresis can markedly reduce CRP in hyperlipidemic patients and biweekly treatment can lower CRP over a period of six months in a small group of ...

Familial hypercholesterolemia is an autosomal dominant disorder resulting in severe elevation of total and LDL cholesterol due to defective hepatic LDL receptor. Heterozygotes occur in about 1 of 500 ...

Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in patients with refractory angina. New ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

Please provide your email address to receive an email when new articles are posted on . TAMPA BAY, Fla. - RheoTherapy, a blood filtration procedure claimed to reverse certain effects of age-related ...

Using apheresis to remove a serum protein called soluble Fms-like tyrosine kinase-1 (Sflt-1) may help pregnant women with severe preeclampsia safely delay delivery, according to a pilot study ...

Trendy, high-end celebrity wellness fads are often prohibitively expensive, which only adds to their mystique. Apheresis — a decades-old medical procedure — was first used in a clinical setting in ...

Rome, Italy – 29 August, 2016: Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in ...